Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
jpmzE5BHNQVC2UwQ